| Primary |
| Product Used For Unknown Indication |
45.9% |
| Hypertension |
24.1% |
| Drug Use For Unknown Indication |
7.1% |
| Depression |
3.4% |
| Overdose |
2.7% |
| Benign Prostatic Hyperplasia |
2.0% |
| Blood Pressure |
2.0% |
| Blood Pressure Increased |
2.0% |
| Type 2 Diabetes Mellitus |
1.7% |
| Duodenal Ulcer |
1.0% |
| Essential Hypertension |
1.0% |
| Heart Transplant |
1.0% |
| Prophylaxis Against Transplant Rejection |
1.0% |
| Bph |
0.7% |
| Coronary Artery Disease |
0.7% |
| Epilepsy |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Migraine |
0.7% |
| Prostatic Disorder |
0.7% |
|
| Pancreatitis Acute |
9.9% |
| Urticaria |
8.5% |
| Circulatory Collapse |
7.0% |
| Joint Swelling |
7.0% |
| Urinary Incontinence |
7.0% |
| Hypoglycaemia |
5.6% |
| Hypotension |
5.6% |
| Weight Increased |
5.6% |
| Withdrawal Syndrome |
5.6% |
| Angioedema |
4.2% |
| Hallucination |
4.2% |
| Psychotic Disorder |
4.2% |
| Renal Failure Acute |
4.2% |
| Syncope |
4.2% |
| Anaphylactic Reaction |
2.8% |
| Convulsion |
2.8% |
| Epilepsy |
2.8% |
| Pancytopenia |
2.8% |
| Renal Failure |
2.8% |
| Sleep Disorder |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
43.7% |
| Hypertension |
26.5% |
| Drug Use For Unknown Indication |
5.1% |
| Overdose |
4.9% |
| Colorectal Cancer |
2.1% |
| Atrial Fibrillation |
1.9% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.7% |
| Suicide Attempt |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Arthralgia |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Blood Pressure Increased |
1.1% |
| Completed Suicide |
1.0% |
| Prinzmetal Angina |
1.0% |
| Pain |
0.9% |
| Benign Prostatic Hyperplasia |
0.8% |
| Prophylaxis Against Transplant Rejection |
0.7% |
| Vasospasm |
0.6% |
| Cardiovascular Disorder |
0.5% |
|
| Pancreatitis Acute |
10.4% |
| Toxicity To Various Agents |
9.6% |
| Overdose |
7.4% |
| Renal Failure Acute |
7.4% |
| Vomiting |
6.7% |
| Weight Loss Poor |
6.7% |
| Renal Failure |
5.9% |
| Syncope |
5.9% |
| Completed Suicide |
5.2% |
| Hypotension |
4.4% |
| Atrial Fibrillation |
3.7% |
| Death |
3.7% |
| Hypertension |
3.7% |
| Bradycardia |
3.0% |
| Electrocardiogram St Segment Depression |
3.0% |
| Multiple Drug Overdose Intentional |
3.0% |
| Orthostatic Hypotension |
3.0% |
| Pleural Effusion |
3.0% |
| Liver Function Test Abnormal |
2.2% |
| Poisoning |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.7% |
| Hypertension |
16.8% |
| Drug Use For Unknown Indication |
13.5% |
| Atrial Fibrillation |
3.0% |
| Diabetes Mellitus |
3.0% |
| Pain |
2.9% |
| Blood Cholesterol Increased |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Prophylaxis |
1.7% |
| Depression |
1.7% |
| Blood Pressure |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Benign Prostatic Hyperplasia |
1.4% |
| Prophylaxis Against Renal Transplant Rejection |
1.1% |
| Cardiac Disorder |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Crohn's Disease |
1.1% |
| Gout |
0.9% |
| Prostatic Disorder |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
|
| Weight Decreased |
10.7% |
| Vomiting |
9.6% |
| Renal Failure Acute |
9.4% |
| Renal Failure |
6.5% |
| Weight Increased |
6.2% |
| Drug Ineffective |
5.8% |
| Syncope |
5.1% |
| Renal Impairment |
4.7% |
| Death |
4.2% |
| Pruritus |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Tremor |
3.8% |
| Vision Blurred |
3.8% |
| Paraesthesia |
3.6% |
| Diarrhoea |
3.3% |
| Nausea |
3.1% |
| Pneumonia |
3.1% |
| Dyspnoea |
2.9% |
| Fatigue |
2.9% |
| Hyperkalaemia |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
26.1% |
| Product Used For Unknown Indication |
17.4% |
| Hypertension |
15.5% |
| Coronary Artery Disease |
6.2% |
| Blood Pressure Abnormal |
3.7% |
| Blood Pressure Increased |
3.1% |
| Hyperlipidaemia |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Depression |
2.5% |
| Diabetes Mellitus |
2.5% |
| Mental Disorder |
2.5% |
| Pain |
2.5% |
| Cardiovascular Disorder |
1.9% |
| Hepatitis C |
1.9% |
| Hepatitis C Virus Test Positive |
1.9% |
| Affective Disorder |
1.2% |
| Benign Prostatic Hyperplasia |
1.2% |
| Cough |
1.2% |
| Diarrhoea |
1.2% |
| Gout |
1.2% |
|
| Syncope |
25.0% |
| Renal Failure Acute |
15.0% |
| Drug Interaction |
10.0% |
| Nocturia |
10.0% |
| Priapism |
10.0% |
| Sedation |
10.0% |
| Epistaxis |
5.0% |
| Hypertension |
5.0% |
| Off Label Use |
5.0% |
| Renal Tubular Acidosis |
5.0% |
|
